Introduction: built-in chromatographic, no cost payload, and cytotoxicity assays help precise DAR characterization crucial to optimizing Secure and productive antibody-drug conjugates in cancer therapy. In the realm of focused most cancers therapies, preserving demanding excellent benchmarks is important, Specially about drug-to-antibody ratios (D